Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0881
D

Failure to Monitor Antibiotic Use and Side Effects

Los Angeles, California Survey Completed on 12-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to implement its antibiotic stewardship and infection prevention and control policies for one resident by not monitoring the use and adverse effects of azithromycin, an antibiotic prescribed for pneumonia. The resident, who had a history of hereditary and idiopathic neuropathy, a history of falls, and severely impaired cognitive skills, was admitted with significant care needs and lacked the capacity to make decisions. The resident received azithromycin over a three-day period, as documented in the Medication Administration Record. Despite facility policy requiring monitoring for antibiotic side effects every shift, there was no documentation in the resident's progress notes indicating that such monitoring occurred during the period the antibiotic was administered. Both the Infection Preventionist and the Director of Nursing confirmed during interviews that nurses are expected to monitor and document for side effects and adverse reactions to antibiotics every shift, but acknowledged that this was not done for this resident. A review of the facility's policies showed that antibiotic usage and outcomes are to be documented using an approved surveillance tracking form, and that all clinical infections treated with antibiotics should be reviewed by the Infection Preventionist or designee. The lack of documentation and monitoring for this resident was inconsistent with these established policies and procedures.

An unhandled error has occurred. Reload 🗙